Ramco Systems rallies 9 per cent over multi-million dollar agreements Ramco Systems rallies 9 per cent over multi-million dollar agreements Abhinav Lahoti / Monday, December 14, 2020 / Article rating: 3.3 Ramco Systems on Monday stated that it has signed four agreements worth multi-million dollars.
Burger King bumper listing; jumps 131 per cent on listing debut Burger King bumper listing; jumps 131 per cent on listing debut DSIJ Intelligence / Monday, December 14, 2020 / Article rating: 5.0 On Monday, Burger King gained by around 131 per cent, touching its high of Rs 18 per share on BSE on the listing debut day.
Sensex, Nifty at record highs; Burger King gains 131 per cent on listing debut, ONGC jumps 5 per cent, Adani Green declines Sensex, Nifty at record highs; Burger King gains 131 per cent on listing debut, ONGC jumps 5 per cent, Adani Green declines DSIJ Intelligence / Monday, December 14, 2020 / Article rating: 3.8 Markets ended close to record highs as Sensex gained by 154.45 points or by 0.34 per cent to settle at 46,253.46 levels while Nifty rose by 44.30 points or 0.33 per cent to close at 13,558.15 levels.
Performance review: Franklin India Focused Equity Fund Performance review: Franklin India Focused Equity Fund DSIJ Intelligence / Monday, December 14, 2020 / Article rating: 4.2 Franklin India Focused Equity fund is a focussed multi-cap fund offering from Franklin Templeton AMC India. Read on to find out more.
Cipla rises more than 4 per cent after settling over cancer drug Revlimid; earnings likely to boost Cipla rises more than 4 per cent after settling over cancer drug Revlimid; earnings likely to boost DSIJ Intelligence / Monday, December 14, 2020 / Article rating: 4.0 Cipla has settled its patent litigation with Celgene over the blockbuster cancer drug Revlimid. Celgene Corporation, a subsidiary of Bristol Myers Squibb, has agreed to provide Cipla with a licence to Celgene’s required patents. Cipla can then sell or manufacture certain volume-limited amounts of generic Lenalidomide in the United States sometime after March 2022.
UPL denies malicious reports against company; stock reacts positively UPL denies malicious reports against company; stock reacts positively DSIJ Intelligence / Monday, December 14, 2020 / Article rating: 4.5 United Phosphorus Limited (UPL) has denied news relating to the forensic audit initiation by SEBI in respect to the whistleblower complaint raised against the company.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high DSIJ Intelligence / Monday, December 14, 2020 / Article rating: 4.1 The market opened in green on December 14, 2020.
Five stocks with selling interest Five stocks with selling interest DSIJ Intelligence / Monday, December 14, 2020 / Article rating: 3.6 The market opened in green on December 14, 2020, overall volumes in futures & options currently stand at 2,09,10,961 contracts with a turnover of Rs. 18,01,927.52 crore.
Five stocks with buying interest Five stocks with buying interest DSIJ Intelligence / Monday, December 14, 2020 / Article rating: 3.8 The market opened in green on December 14, 2020, overall volumes in futures & options currently stand at 2,09,10,961 contracts with a turnover of Rs. 18,01,927.52 crore.
European Commission expresses positive opinion on rapid-acting insulins of Biocon Biologics European Commission expresses positive opinion on rapid-acting insulins of Biocon Biologics DSIJ Intelligence / Monday, December 14, 2020 / Article rating: 5.0 A subsidiary of Biocon Limited i.e. Biocon Biologics and Mylan, a subsidiary of Viatris Inc., have received a positive opinion from European Medicines Agency's committee for medicinal products for human use (CHMP), recommending approval of the market authorisation of Kixelle, a biosimilar Insulin Aspart, which is rapid-acting insulin for the treatment of type 1 and 2 diabetes.